ILC1 as critical gatekeepers in autoimmune kidney damage
Authors:
- 6 December 2024
- journal article
- research article
- Published by Wiley in Immunology & Cell Biology
- Vol. 103 (1) , 9-11
Abstract
A recent article has shown that blocking NKp46 signaling reduces injury, highlighting these cells as key drivers of organ damage and potential therapeutic targets in autoimmune diseases. In lupus nephritis, NKp46+ ILC1s orchestrate kidney inflammation by producing CSF2, driving the expansion of pro-inflammatory macrophages that infiltrate epithelial niches and exacerbate tissue damage.Keywords
This publication has 5 references indexed in Scilit:
- Amplification of autoimmune organ damage by NKp46-activated ILC1sNature, 2024
- Innate lymphoid cell disturbance with increase in ILC1 in systemic lupus erythematosusClinical Immunology, 2019
- Macrophages: versatile players in renal inflammation and fibrosisNature Reviews Nephrology, 2019
- Innate Lymphoid Cells: 10 Years OnCell, 2018
- Complement factor P is a ligand for the natural killer cell–activating receptor NKp46Science Immunology, 2017